University of Patras
Ρυθμιστές της δυναμικής του κυτταροσκελετού ακτίνης και επιθήλιο - μεσεγχυματική μετατροπή (ΕΜΤ) στον καρκίνο του παχέος εντέρου στον άνθρωπο
Abstract
dc:descriptionUnderstanding the molecular mechanisms underlying colorectal cancer (CRC) progression is of great importance since invasion and metastasis is the major cause of CRC related morbidity and mortality. Actin cytoskeleton regulates cellular functions fundamental to cancer cells such as cell proliferation and migration. Reorganization of the actin cytoskeleton conferring increased migratory capacity is also fundamental to the epithelial-mesenchymal transition (EMT), a developmental program exploited by cancer cells in order to acquire the ability to invade and metastasize.Actin-filament dynamics is regulated by actin-binding proteins that control polymerization and depolymerization of actin filaments and formation of actin-based bundles and cellular protrusions (Yamaguchi et al., 2007;dos Remedios et al., 2002). Cofilin is an actin-binding protein essential for actin-filament turnover, as it depolymerizes and severs actin filaments and it is known to have an important and complex role in cancer progression. Cofilin activity is regulated by phosphorylation-dephosphorylation at Ser3. Negative regulation of cofilin by phosphorylation at Ser 3 is mediated by LIM kinases (LIMKs), namely LIMK1 and LIMK2, while reactivation is processed by Slingshot protein phosphatases (SSH). Another important regulator of actin-filament nucleation is the N-WASP an important activator of the Arp2/3 complex. LIMKs, SSH and N-WAS are implicated in lamellipodia and invadopodia formation and in directional cell migration and they also have significant role in cancer cell invasion .Overexpression of LIMKs, SSH and N-WASP has been reported in human cancer. However, only a few studies with opposing results have addressed the role of LIMKs and N-WASP in colon cancer and there is no published data, to the best of our knowledge, regarding SSH expression in human CRC.In this respect, we evaluated the expression of non-phosphorylated (active) and phosphorylated cofilin, LIMK1, LIMK2, SSH1 and N-WASP by immunohistochemistry in 143 human CRC samples in relation to clinicopathologic parameters, response of metastatic disease to chemotherapy and epithelial-mesenchymal transition (EMT) markers β-catenin, E-cadherin, ZEB and Twist. We also evaluated expression of these F-actin regulators in human colon cancer cells with acquired resistance to 5-fluorouracil (5-FU). We show that active cofilin, LIMK1, LIMK2, SSH1 and N-WASP are overexpressed in human CRC and are associated with tumor progression parameters. SSH1 is an independent predictor of lymph node metastasis by multivariate analysis. LIMK1 and SSH1 expression is also higher in non-responders to chemotherapy and SSH1 is shown by multivariate analysis to independently predict response of metastatic disease to chemotherapy. Active cofilin, LIMK1, LIMK2, SSH1 and N-WASP also correlated with the EMT markers examined. In addition, immunofluorescence analysis showed increased expression of active cofilin, LIMK1, LIMK2 and SSH1 in HT29 colon cancer cells resistant to 5-fluorouracil compared to parental HT29 cells. Our results suggest that F-actin regulators LIMK/cofilin pathway, SSH1 and N-WASP are associated with CRC progression and chemoresistance representing promising tumour biomarkers and therapeutic targets in CRC.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Angelou, Eleni
- Αγγέλου, Ελένη
Subjects
dc:subject × 19- Καρκίνος παχέος εντέρου
- Κυτταροσκελετός ακτίνης
- Ρυθμιστές κυτταροσκελετου ακτίνης
- Χημειοαντίσταση
- Επιθήλιο - μεσεγχυματική μετατροπή
- EMT
- Colon cancer
- Chemoresistance
- Limk /cofilin
- Slingshot
- Limk1
- Limk2
- Cofilin
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45276